Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
PANITUMUMAB 100 MG/5 ML (20 MG/ML) INTRAVENOUS SOLUTION (NDC 55513-954-21) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 1, 2026 , from http://ppman.hank.ai/transparency/procedure/55513-954-21/by-state?code_type=NDC
“PANITUMUMAB 100 MG/5 ML (20 MG/ML) INTRAVENOUS SOLUTION (NDC 55513-954-21) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/55513-954-21/by-state?code_type=NDC. Accessed
November 1, 2026 .
“PANITUMUMAB 100 MG/5 ML (20 MG/ML) INTRAVENOUS SOLUTION (NDC 55513-954-21) by State,” HANK Price Transparency ,
accessed November 1, 2026 ,
http://ppman.hank.ai/transparency/procedure/55513-954-21/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
55513-954-21 — Panitumumab 100 Mg/5 Ml (20 Mg/ml) Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$16,954
National median
$16,954 – $16,954
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 55513-954-21 (NDC), with interquartile range
State Median p25 p75
MD $16,954 $16,954 $16,954